{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T11:19:15Z","timestamp":1707736755777},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1097\/inf.0000000000000487","type":"journal-article","created":{"date-parts":[[2014,7,10]],"date-time":"2014-07-10T15:54:17Z","timestamp":1405007657000},"page":"47-51","source":"Crossref","is-referenced-by-count":7,"title":["Cidofovir in Pediatric Solid Organ Transplant Recipients"],"prefix":"10.1097","volume":"34","author":[{"given":"Diana F.","family":"Florescu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather E.","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan A.","family":"Keck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David F.","family":"Mercer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael C.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marius C.","family":"Florescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R3-10-20210202","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1399-3062.2009.00391.x","article-title":"Safety and tolerability of cidofovir in high-risk pediatric patients.","volume":"11","author":"Bhadri","year":"2009","journal-title":"Transpl Infect Dis"},{"key":"R4-10-20210202","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1399-3046.2005.00391.x","article-title":"Intermediate-dose cidofovir without probenecid in the treatment of BK virus allograft nephropathy.","volume":"10","author":"Araya","year":"2006","journal-title":"Pediatr Transplant"},{"key":"R5-10-20210202","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1399-3046.2008.00937.x","article-title":"Intermediate dose cidofovir does not cause additive nephrotoxicity in BK virus allograft nephropathy.","volume":"12","author":"Araya","year":"2008","journal-title":"Pediatr Transplant"},{"key":"R6-10-20210202","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.healun.2007.06.009","article-title":"Treatment of adenovirus pneumonia with cidofovir in pediatric lung transplant recipients.","volume":"26","author":"Doan","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"R7-10-20210202","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1097\/00007890-200210150-00027","article-title":"Intravenous cidofovir therapy for disseminated adenovirus in a pediatric liver transplant recipient.","volume":"74","author":"Carter","year":"2002","journal-title":"Transplantation"},{"key":"R8-10-20210202","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1182\/blood.V97.2.388","article-title":"Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The infectious diseases working party of the European group for blood and marrow transplantation.","volume":"97","author":"Ljungman","year":"2001","journal-title":"Blood"},{"key":"R9-10-20210202","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/TP.0b013e3181e0de97","article-title":"Adenovirus infections in pediatric small bowel transplant recipients.","volume":"90","author":"Florescu","year":"2010","journal-title":"Transplantation"},{"key":"R12-10-20210202","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1086\/517222","article-title":"Successful treatment of adenovirus disease with intravenous cidofovir in an unrelated stem-cell transplant recipient.","volume":"28","author":"Ribaud","year":"1999","journal-title":"Clin Infect Dis"},{"key":"R13-10-20210202","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1182\/blood.V122.21.3292.3292","article-title":"The effectiveness of cidofovir in disseminated adenovirus infections after pediatric HSCT is closely related to lymphocyte reconstitution.","volume":"122","author":"Lugthart","year":"2013","journal-title":"Blood"},{"key":"R14-10-20210202","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.healun.2007.06.009","article-title":"Treatment of adenovirus pneumonia with cidofovir in pediatric lung transplant recipients.","volume":"26","author":"Doan","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"R15-10-20210202","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1681\/ASN.V113383","article-title":"Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1.","volume":"11","author":"Ho","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"R16-10-20210202","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s11095-006-9196-x","article-title":"Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2).","volume":"24","author":"Uwai","year":"2007","journal-title":"Pharm Res"},{"key":"R17-10-20210202","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1124\/jpet.105.084301","article-title":"Functional consequences of single nucleotide polymorphisms in the human organic anion transporter hOAT1 (SLC22A6).","volume":"314","author":"Bleasby","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"R18-10-20210202","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1136\/adc.2008.153601","article-title":"Sonographic long-term study: paediatric growth charts for single kidneys.","volume":"94","author":"Spira","year":"2009","journal-title":"Arch Dis Child"},{"key":"R19-10-20210202","first-page":"152","article-title":"Mechanisms of compensatory renal growth.","volume":"10","author":"Cleper","year":"2012","journal-title":"Pediatr Endocrinol Rev"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000000487","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,10]],"date-time":"2022-04-10T21:08:04Z","timestamp":1649624884000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201501000-00010"}},"subtitle":["University of Nebraska Experience"],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000000487","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]}}}